Skip to Content

TEVA 7617 (Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg)

Pill with imprint TEVA 7617 is Yellow, Elliptical / Oval and has been identified as Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 25 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7617

Hydrochlorothiazide and olmesartan medoxomil 25 mg / 40 mg TEVA 7617

Hydrochlorothiazide and Olmesartan Medoxomil

Imprint:
TEVA 7617
Strength:
25 mg / 40 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Angiotensin II inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC):
00093-7617

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide